ClinicalTrials.govpublic full text
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm, metastatic lung non-small cell carcinoma, metastatic triple-negative breast carcinoma, recurrent acute lymphoblastic leukemia, recurrent mantle cell lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 256861
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.